Have you heard about induced pluripotent stem cells (iPS cells), but don’t know exactly what they are and what they can do? If so, read on to learn the answers to frequently asked questions (FAQs) about iPS cells.
In this article:
Hopstem’s iPSC-Derived hNPC01 Cell Therapy Gains FDA Clearance to Target Three Major Brain Injury Indications
Hopstem Receives U.S. FDA IND Clearance and Fast Track designations for hNPC01 in Hemorrhagic Stroke and Traumatic Brain Injury-Expanding Clinical Development Across Three Major Brain Injury Indications
HOUSTON, July 29, 2026 — Hopstem Biotechnology announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application and Fast Track designations for hNPC01, an allogeneic induced pluripotent stem cell (iPSC)-derived forebrain neural progenitor cell therapy, for the treatment of chronic motor dysfunction due to Hemorrhagic Stroke (ICH) and Traumatic Brain Injury (TBI). [Read more…]
What is Lab-Grown Meat and Why Does It Matter?
The potential of lab-grown meat has captured the attention of investors, researchers, food companies, and biotechnology leaders worldwide. Although the concept of producing meat from animal cells has existed for decades, the cultivated meat industry has evolved from an academic research field into an emerging commercial biotechnology sector. [Read more…]
Clean Meat Market: Stem Cell Derived “Clean Meat” Attracts Billionaires
Lab-grown meat, now more commonly referred to as cultivated meat, cell-cultured meat, or cellular agriculture, has evolved from a speculative biotechnology concept into an emerging commercial sector attracting investors, biotechnology companies, food industry leaders, and researchers worldwide.
Produced by expanding animal cells from species such as cattle, pigs, chicken, fish, and other livestock within controlled bioreactor environments, cultivated meat has the potential to reshape portions of the global protein market. Rather than raising and slaughtering animals, cultivated meat companies use cellular agriculture techniques to produce animal-derived tissues directly from cells. [Read more…]
Induced Pluripotent Stem Cell (iPS Cell) Applications in 2026
Since the discovery of induced pluripotent stem cell (iPSC) technology 20 years ago in 2006, significant progress has been made in stem cell biology and regenerative medicine. New pathological mechanisms have been identified, new drugs identified by iPSC screens are in the pipeline, and the first clinical trials employing human iPSC-derived cell types have been initiated. [Read more…]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 79
- Next Page »